Nasir K.: The Global Healthcare Community Comes Together for IPAW 2026
Nasir K., Chief Executive Officer at Global Medical Consultancy, shared a post on LinkedIn:
“Today marks the start of International Plasma Awareness Week.
This week (October 5-9), the global healthcare community comes together for International Plasma Awareness Week (IPAW 2026) to thank incredible donors and highlight a critical need in healthcare.
Plasma makes up about 55% of our blood.
Often called ‘liquid gold,’ and it’s vital proteins and antibodies are used to create therapies for rare, chronic, and genetic conditions – like primary immunodeficiencies and bleeding disorders.
These lifesaving medicines cannot be synthetically created in a lab.
They rely 100% on the generosity of human donors.
For hundreds of thousands of patients worldwide, a plasma donation isn’t just medicine; it’s a lifeline.
Looking at this from a Pakistani perspective, the conversation becomes even more urgent.
Currently, Pakistan is not yet into commercial source plasma collection, meaning our healthcare system relies heavily on expensive, imported plasma-derived products to save lives.
But things are changing.
With a massive, young population and millions of whole blood bags collected annually, we sit on incredible potential.
By building local plasma infrastructure, we can transition from a state of importing dependency to healthcare self-reliance – saving both foreign exchange and, more importantly, Pakistani lives.
How we can all support the cause this week:
- Educate to help destigmatize and raise awareness about the donation process.
- Support local progress, policies and partnerships aimed at bringing safe, localized blood component separation and plasma-farming facilities to Pakistan.
- Keep supporting our local blood banks by continuing to donate whole-blood as Recovered plasma from regular blood donations is the stepping stone toward a self-sufficient ecosystem!”

Stay updated with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines